D-1246-2019 Class III Terminated
FDA drug recall D-1246-2019 was initiated by LUPIN SOMERSET on Apr 10, 2019 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Oct 14, 2022). Affected quantity: 3,444 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- May 1, 2019
- Initiation Date
- Apr 10, 2019
- Termination Date
- Oct 14, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,444 bottles
Product description
Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-543-01
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
Product was shipped to 5 wholesalers and one Supermarket Chain who may have further distributed the product throughout the United States.
Code information
Lot#: S700223 Exp. Apr 30 2019; S800467, Exp. Mar 31 2020.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1246-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026